Fundraising Fox

Sten Verland

Investor

Venture Partner at Sunstone Capital

Denmark

About

Sten Verland is a venture partner and founding partner at Sunstone Life Science Ventures who brings experience in executive management, venture capital, and pharmaceutical development. He holds a PhD in Immunology and has served as a CEO, board member, and chairman across biotech and pharmaceutical companies, with expertise in drug development, M&A, and fundraising. Verland also participates in innovation funding committees supporting early-stage life science ventures.

Experience

  1. Sunstone Life Science VenturesVenture Partner (founding partner)current2024 — presentCopenhagen Metropolitan Area
  2. Sunstone Life Science VenturesGeneral Partner (founding partner)2007 — 2024Copenhagen Metropolitan Area
  3. Verland - Life Science Venture & ConsultingCEO & Ownercurrent1994 — presentCopenhagen Metropolitan Area
  4. Minervax ApSNon Executive Directorcurrent2014 — presentCopenhagen Metropolitan Area
  5. Minervax ApSChair of the Audit Committeecurrent2020 — presentCopenhagen Metropolitan Area
  6. Sulis TherapeuticsChair of the Board of Directorscurrent2026 — presentAarhus, Central Denmark Region, Denmark
  7. Proxi BiotechChair of the Board of Directorscurrent2025 — presentCoopenhagen, Denmark
  8. Innovation Fund DenmarkMember of the InnoFounder selection committeecurrent2014 — presentCopenhagen Metropolitan Area
  9. Innovation Fund DenmarkMember of the InnoExplorer selection committee2019 — 2024Copenhagen Metropolitan Area
  10. Innovation Fund DenmarkMember of the InnoBooster selection committee2018 — 2021Copenhagen Metropolitan Area
  11. Skovlyst Production A/SNon Executive Directorcurrent2018 — presentCopenhagen Metropolitan Area
  12. Skovlyst Production A/SPrivate investor (through Verland Capital ApS)current2009 — presentCoopenhagen, Denmark
  13. The Research Council of NorwayPanel Member2020 — 2025Oslo, Norway
  14. Neumirna TherapeuticsChair of the Board of Directors2022 — 2025Copenhagen Metropolitan Area
  15. Anergis SANon Executive Director2011 — 2024Lausanne, Vaud, Switzerland
  16. Stipe TherapeuticsMember of the Audit Committee2019 — 2024Aarhus, Central Denmark Region, Denmark
  17. Stipe TherapeuticsNon Executive Director2019 — 2024Aarhus, Central Denmark Region, Denmark
  18. Vaximm AGBoard Observer2019 — 2022Basel, Switzerland
  19. Vaximm AGNon Executive Director2011 — 2019Basel, Switzerland
  20. OxTheraNon Executive Director2016 — 2022Greater Stockholm Metropolitan Area

Education

  1. Københavns Universitet - University of CopenhagenDoctor of Philosophy - PhD, Immunology1988 — 1990
  2. Københavns Universitet - University of CopenhagenMaster of Science - MSc, Biology and Mathematics1979 — 1986

Skills & more

Venture Capital59Biotechnology45Entrepreneurship37Drug Development19Lifesciences19Mergers9Business Strategy12Immunology12Corporate Development9Mergers & Acquisitions8R&D6Clinical Development5
+12 moreStrategyExecutive ManagementPrivate EquityPharmaceutical IndustryAngel InvestingVenture FinancingClinical TrialsIPONegotiationAdvisory BoardsStart-upsCommercialization

Languages Danish · English · German · Other Scandinavian languages

From Sten's professional profile.

Same school

Shared employers

Colleagues at Sunstone Capital